版块导航: 正在加载中...

登录注册

应《网络安全法》要求，自2017年10月1日起，未进行实名认证将不得使用互联网跟帖服务。为保障您的帐号能够正常使用，请尽快对帐号进行手机号验证，感谢您的理解与支持！

24小时热门版块排行榜

>论坛更新日志 (5317)
>虫友互识 (493)
>文献求助 (213)
>休闲灌水 (178)
>基金申请 (141)
>硕博家园 (125)
>招聘信息布告栏 (100)
>教师之家 (84)
>导师招生 (81)
>论文投稿 (72)
>博后之家 (59)
>考博 (44)
>找工作 (23)
>环境 (21)
>有机交流 (20)
>考研 (19)

返回列表

【有奖交流】积极回复本帖子，参与交流，就有机会分得作者 FrozenM00N 的 2 个金币，回帖就立即获得 1 个金币，每人有 1 次机会

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

FrozenM00N

捐助贵宾 (初入文坛)

应助: 0 (幼儿园)
金币: 26.5
帖子: 14
在线: 23.9小时
虫号: 32405220

[交流] 美国犹他大学分子影像和纳米材料方向招收全额奖学金博士、博士后以及访问学者

美国犹他大学是美国犹他州的高等教育旗舰型大学，也是一所世界顶尖的公立研究型大学，为特高研究型大学（Top-tier Research university）。2021U.S. News美国最佳公立大学排名第40位，2022WRWU世界大学排名第63位，2022软科世界大学学术排名第101-150，2022U.S. News世界大学排名第151位。

博后入职可选药学院。犹他大学药学院是本校王牌学科，全美药学院排名#14位（U.S. News）。

Dr. Sixiang Shi Lab招收博士生（全额奖学金）一名，博士后一名，并欢迎访问学者前来一起工作。课题组主要研究分子影像、生物材料、靶向治疗、免疫疗法等方向。Dr. Shi共发表40余篇文章（引用>3900, H因子30），包括 ACS Nano, Advanced Drug Delivery Reviews, Angewandte Chemie, Biomaterials, JNM, Nature Nanotechnology等本领域顶级期刊。担任Journal of Nanobiotechnology（IF=9.429)副主编，并获得 SNMMI Ones to Watch 2020等诸多荣誉。

招生要求：
1. 分子影像、生物、化学、材料等相关背景的硕士研究生或者本科四年级学生。
2. 学习成绩优异，有钻研精神。有科研经历和论文发表者优先。
3. 有良好的英文基础，达到托福80分或者雅思6.5分。

研究课题：分子影像、纳米材料、免疫疗法。

有意者请联系sixiang.shi@utah.edu
网页：https://imagingnanolabs.com/

具体招生信息如下：

The Molecular Imaging and Nanotechnology Innovation Laboratory (MINILabs) is seeking graduate students, postdoctoral fellows, and visiting scholars to lead research efforts at the intersection of molecular imaging and nanomedicine. Our core mission is to revolutionize the way we visualize, understand and treat cancer and other diseases, by potentiating simple but powerful solutions to biomedical and healthcare challenges.

Laboratory Research Directions:
1.       Application of advanced molecular imaging techniques (PET/CT, optics, optoacoustic imaging, etc.) in cancer, regenerative medicine and other diseases;
2.       Development of innovative nanomedicine and natural biomaterials (e.g. extracellular vesicles) for personalized theranostics;
3.       Development of novel radiochemistry and targeted radiotherapy for refractory diseases;
4.       Utilizing advanced imaging tools to understand the biological unknowns in tumor microenvironment, metastasis, immunology, etc.

Trainees will be a part of a highly multidisciplinary and collaborative group within the Department of Radiology and Imaging Sciences and the Department of Molecular Pharmaceutics at the University of Utah, led jointly by PIs Dr. Shi and Dr. Goel. The excellent academic environment at the University of Utah offers excellent career development and enhancement opportunities at all levels.

Applicant Requirements:
1.       Familiarity with advanced techniques in molecular biology, biomedical imaging and biomaterials research is preferred.
2.       Successful candidates will be motivated, curious and independent thinkers with a strong sense of responsibility and good oral and written communication skills.
3.       Applicants for PhD program should be final-year masters/4th-year undergraduate students or the students who recently graduated.
4.       The students exhibiting outstanding performance with excellent GPA and research track record will be given preference.
5.       The international students must successfully complete the English Proficiency Test (TOEFL 80 or IELTS 6.5).
6.       Applicants for postdoctoral fellows with outstanding publication record and ability to work independently will be given priority.

Contact: Interested candidates are recommended to send their CVs to Dr. Sixiang Shi (sixiang.shi@utah.edu).

Principal Investigator (PI): Dr. Sixiang Shi received his PhD degree in Materials Science and Engineering from the University of Wisconsin-Madison in 2016 and completed his postdoctoral fellowship from MD Anderson Cancer Center in 2020. He shortly worked in the Department of Health Technology and Informatics at the Hong Kong Polytechnic University as an Assistant Professor in 2021. He joined the Department of Radiology and Imaging Sciences at the University of Utah in August 2022. So far, he has published >40 papers (>3900 citations, h-index: 30), in top journals such as ACS Nano, Advanced Drug Delivery Reviews， Angewandte Chemie, Biomaterials, JNM, Nature Nanotechnology, among others. Dr. Shi serves as Associate Editor for Journal of Nanobiotechnology, Editorial Member for Journal of Functional Biomaterials, and reviewer for more than 20 journals, scientific societies, grants agencies and conferences. Dr. Shi has received multiple awards and honors for his research and scholarship, including the SNMMI Ones to Watch 2020, which recognizes most promising researchers worldwide in the fields of nuclear medicine and molecular imaging. Details can be found via https://imagingnanolabs.com/.

回复此楼

» 猜你喜欢

» 本主题相关商家推荐: (我也要在这里推广)

» 抢金币啦！回帖就可以得到:
查看全部散金贴

1楼2023-05-04 12:40:21

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

相关版块跳转我要订阅楼主 FrozenM00N 的主题更新